Galaxy Medicare IPO Details

Incorporated in July 1992, Galaxy Medicare Limited is a well-established Indian manufacturer, trader, and exporter of medical devices, Plaster of Paris (POP) bandages, surgical dressings, and wound care products. With over three decades of industry presence, the company has built a strong reputation for quality and reliability in both domestic and international markets.

Core Products and Specializations

Galaxy Medicare manufactures a wide range of healthcare and surgical products using premium-grade raw materials sourced from reputed vendors. Its core product portfolio includes:

• Surgical dressings
• Plaster of Paris bandages
• Adhesive tapes
• Compression bandages
• Wound care and orthopedic solutions

These products cater to a broad spectrum of medical requirements, serving hospitals, healthcare institutions, and distributors across India and abroad.

Business Operations

The company's operations are diversified across the following key areas:

• In-house Manufacturing & Branding: Products are sold under well-known proprietary brands, including POP BAND, POP CAST, G CAST, GYPSOSOFT, GYPSOPLAST, CARETAPE, GYPSOCREPE, CARECREPE, CAREPORE, GYPSONET, GYPSOCHLOR, and FIXCAN.
• OEM Manufacturing: Galaxy Medicare offers contract manufacturing services, developing and testing products to meet the specific requirements of brand owners on a Principal-to-Principal basis.
• Institutional Sales: Supplies to various central and state government health departments through tender participation on the Government e-Marketplace (GeM) portal.
• Exports & Trading: The company exports its products internationally, especially to neighboring countries like Bangladesh and Nepal, while also engaging in the trade of surgical devices and dressings.

As of March 2025, Galaxy Medicare employs 190 personnel across departments including production, quality, sales, and R&D.

Trademarks and Certifications

• Holds 27 registered trademarks in India, supporting brand recognition and product differentiation.
• Complies with ISO 9001:2015 and ISO 13485:2016 quality standards, ensuring that all products meet the rigorous expectations of global healthcare institutions.

Market Presence and Financial Highlights

Galaxy Medicare has developed a widespread distribution network across India, supplying to:

• Central and state government health departments
• Corporate hospitals
• Private healthcare providers

The company has also maintained strong export performance:

• INR 8.47 crore in export revenue for FY 2023-24 (up from INR 7.27 crore in FY 2022-23)
• INR 3.93 crore in exports during the half-year ended September 30, 2024

Competitive Strengths

• Experienced Leadership and Skilled Management
• Established Brand Reputation and Customer Relationships
• Consistent Focus on Quality Compliance
• State-of-the-Art Manufacturing Facilities
• In-house QA/QC and R&D Capabilities
• Expanding Global Presence

Galaxy Medicare Limited continues to drive growth through product innovation, operational excellence, and a strong commitment to quality. With a well-diversified portfolio and a growing global footprint, the company remains a trusted partner in the healthcare industry.